Salarius Pharmaceuticals
Salarius Pharmaceuticals is a biotechnology company that focuses on developing therapies to treat cancer.
Business Model:
Revenue: $606k
Employees: 11-50
Rankings
Industries / Tags:
Detailed Salarius Pharmaceuticals Information
Geographic Data
Address: 2450 Holcombe Blvd
City: Houston
State: TX
Zip: 77021
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$2M
Raised Total:$2M
Social
Metrics
4,841,557Website Global Rank
1,771Website Monthly Traffic
Twitter Followers
Description
Salarius Pharmaceuticals is a biotechnology company that focuses on developing therapies to treat cancer.
Contact Phone:
Contact Email:
Salarius Pharmaceuticals went public on 1/30/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/30/2015
Ticker Symbol:
SLRX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Grant | 1 | $2.7M |
Cancer Prevention and Research Institute of Texas Cancer Prevention and Research Institute of Texas |
4/2022 | Post-IPO Equity | $2.3M | 3/2021 | Post-IPO Equity | $23M | 5/2018 | Venture Round | 1 | - |
Tech Coast Angels Tech Coast Angels |
11/2016 | Venture Round | $1M | 11/2018 | Equity | - | 4/2020 | Debt | $150k |
U.S. Small Business Administration. |
11/2018 | Equity | - |
Mid Atlantic Bio Angels Mid Atlantic Bio Angels |
5/2018 | Venture Round | 1 | - |
Tech Coast Angels Tech Coast Angels |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
